197 related articles for article (PubMed ID: 15541846)
1. Endometrial adenocarcinoma in young patients: evaluation and fertility-preserving treatment.
Benshushan A
Eur J Obstet Gynecol Reprod Biol; 2004 Dec; 117(2):132-7. PubMed ID: 15541846
[TBL] [Abstract][Full Text] [Related]
2. A review of the challenges faced in the conservative treatment of young women with endometrial carcinoma and risk of ovarian cancer.
Zivanovic O; Carter J; Kauff ND; Barakat RR
Gynecol Oncol; 2009 Dec; 115(3):504-9. PubMed ID: 19758691
[TBL] [Abstract][Full Text] [Related]
3. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
[TBL] [Abstract][Full Text] [Related]
4. Occult myometrial recurrence after progesterone therapy to preserve fertility in a young patient with endometrial cancer.
Hurst SA; Hartzfeld KM; Del Priore G
Fertil Steril; 2008 Mar; 89(3):724.e1-3. PubMed ID: 17570366
[TBL] [Abstract][Full Text] [Related]
5. Endometrial cancer and fertility.
Rackow BW; Arici A
Curr Opin Obstet Gynecol; 2006 Jun; 18(3):245-52. PubMed ID: 16735822
[TBL] [Abstract][Full Text] [Related]
6. Conservative management of young patients with endometrial highly-differentiated adenocarcinoma.
Kalogiannidis I; Agorastos T
J Obstet Gynaecol; 2011; 31(1):13-7. PubMed ID: 21280986
[TBL] [Abstract][Full Text] [Related]
7. [Endometrial adenocarcinoma in women 40 years old or younger by treatment with progestins: report of 6 cases and review of the literatures].
Wang HY; Shen L; Sun Z
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):237-41. PubMed ID: 16759457
[TBL] [Abstract][Full Text] [Related]
8. Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women.
Ushijima K; Yahata H; Yoshikawa H; Konishi I; Yasugi T; Saito T; Nakanishi T; Sasaki H; Saji F; Iwasaka T; Hatae M; Kodama S; Saito T; Terakawa N; Yaegashi N; Hiura M; Sakamoto A; Tsuda H; Fukunaga M; Kamura T
J Clin Oncol; 2007 Jul; 25(19):2798-803. PubMed ID: 17602085
[TBL] [Abstract][Full Text] [Related]
9. [Clinical analysis of endometrial carcinoma patients aged 45 years and younger].
Gao JS; Shen K; Lang JH; Huang HF; Pan LY; Wu M; Jin Y; Chen QH
Zhonghua Fu Chan Ke Za Zhi; 2004 Mar; 39(3):159-61. PubMed ID: 15130373
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium.
Park H; Seok JM; Yoon BS; Seong SJ; Kim JY; Shim JY; Park CT
Arch Gynecol Obstet; 2012 Feb; 285(2):473-8. PubMed ID: 21706284
[TBL] [Abstract][Full Text] [Related]
11. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review.
Ramirez PT; Frumovitz M; Bodurka DC; Sun CC; Levenback C
Gynecol Oncol; 2004 Oct; 95(1):133-8. PubMed ID: 15385122
[TBL] [Abstract][Full Text] [Related]
12. [Endometrial adenocarcinoma during the fertile age].
Franchi M; Tenti P; Ghezzi F; Beretta P; Tusei A; Zanaboni F
Minerva Ginecol; 1993; 45(1-2):13-7. PubMed ID: 8469359
[TBL] [Abstract][Full Text] [Related]
13. Young patients with endometrial cancer: how many could be eligible for fertility-sparing treatment?
Navarria I; Usel M; Rapiti E; Neyroud-Caspar I; Pelte MF; Bouchardy C; Petignat P
Gynecol Oncol; 2009 Sep; 114(3):448-51. PubMed ID: 19560801
[TBL] [Abstract][Full Text] [Related]
14. Fertility-preserving treatment in young women with well-differentiated endometrial carcinoma and severe atypical hyperplasia of endometrium.
Yu M; Yang JX; Wu M; Lang JH; Huo Z; Shen K
Fertil Steril; 2009 Dec; 92(6):2122-4. PubMed ID: 19591991
[TBL] [Abstract][Full Text] [Related]
15. Conservative surgical management of stage IA endometrial carcinoma for fertility preservation.
Mazzon I; Corrado G; Masciullo V; Morricone D; Ferrandina G; Scambia G
Fertil Steril; 2010 Mar; 93(4):1286-9. PubMed ID: 19700153
[TBL] [Abstract][Full Text] [Related]
16. Outcome of fertility-preserving treatment in young women with endometrial carcinomas.
Niwa K; Tagami K; Lian Z; Onogi K; Mori H; Tamaya T
BJOG; 2005 Mar; 112(3):317-20. PubMed ID: 15713146
[TBL] [Abstract][Full Text] [Related]
17. Endometrial cancer in women 40 years old or younger.
Duska LR; Garrett A; Rueda BR; Haas J; Chang Y; Fuller AF
Gynecol Oncol; 2001 Nov; 83(2):388-93. PubMed ID: 11606102
[TBL] [Abstract][Full Text] [Related]
18. Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin.
Park JY; Lee SH; Seong SJ; Kim DY; Kim TJ; Kim JW; Kim JH; Kim YM; Kim YT; Bae DS; Nam JH
Gynecol Oncol; 2013 Apr; 129(1):7-11. PubMed ID: 23283299
[TBL] [Abstract][Full Text] [Related]
19. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
20. Successful pregnancy after conservative surgery for stage IA endometrial cancer in a young woman.
Yasuda M; Terai Y; Sekijima T; Sasaki H; Yamashita Y; Kanemura M; Ohmichi M
Fertil Steril; 2009 Mar; 91(3):936.e13-5. PubMed ID: 19062001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
